What are the recommended non-scheduled drugs for managing insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Non-Scheduled Drugs for Managing Insomnia

For patients with primary insomnia requiring pharmacological treatment, sedating antidepressants (trazodone, amitriptyline, doxepin, mirtazapine) are the recommended non-scheduled medications, especially when used in conjunction with treating comorbid depression/anxiety. 1

First-Line Approach

  • Cognitive Behavioral Therapy for Insomnia (CBT-I) should be considered the initial treatment for chronic insomnia before or alongside pharmacological options 1, 2
  • When pharmacotherapy is necessary, treatment selection should be guided by symptom pattern, treatment goals, past responses, patient preference, cost, and comorbid conditions 1

Recommended Non-Scheduled Medications

Sedating Antidepressants

  • Trazodone, amitriptyline, doxepin, and mirtazapine are the primary non-scheduled options for insomnia management 1, 3
  • Doxepin liquid (3-6 mg) is particularly effective for sleep maintenance insomnia and available in liquid form 4
  • Mirtazapine can be beneficial for patients with comorbid depression and insomnia 3, 4
  • Trazodone (typically 50 mg) is commonly used though evidence is more limited compared to other options 3, 4

Other Non-Scheduled Options

  • Anti-epilepsy medications (gabapentin, tiagabine) may be considered for patients with comorbid conditions that would benefit from their primary action 1, 3
  • Atypical antipsychotics (quetiapine, olanzapine) should only be used in patients with comorbid psychiatric conditions that would benefit from their primary mechanism of action 1, 3
  • Melatonin, while available over-the-counter, is not strongly recommended by guidelines for primary insomnia due to limited efficacy data 1, 5

Medications to Avoid

  • Over-the-counter antihistamine sleep aids are not recommended due to lack of efficacy and safety data 1
  • Herbal substances such as valerian are not recommended due to insufficient evidence 1
  • Older drugs including barbiturates, barbiturate-type drugs, and chloral hydrate are not recommended 1

Administration Guidelines

  • Start with the lowest effective dose and titrate as needed 1
  • Pharmacological treatment should be accompanied by patient education regarding treatment goals, safety concerns, potential side effects, and other treatment modalities 1
  • Regular follow-up is essential to assess effectiveness, monitor for side effects, and evaluate the ongoing need for medication 1
  • Efforts should be made to use the lowest effective maintenance dosage and to taper medication when conditions allow 1

Special Considerations

  • For patients requiring administration through PEG tubes, doxepin liquid is ideal; alternatively, trazodone and mirtazapine can be crushed and dissolved in water 4
  • In elderly patients, lower doses should be used due to increased sensitivity to side effects 3, 4
  • For patients with a history of substance use disorders, non-scheduled medications are preferred over controlled substances 3, 6

Monitoring and Follow-up

  • Assess efficacy after 1-2 weeks of treatment initiation 4
  • Monitor for side effects including excessive sedation, confusion, and falls, especially in elderly patients 4, 6
  • Long-term prescribing should include consistent follow-up, ongoing assessment of effectiveness, and monitoring for adverse effects 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insomnia.

Lancet (London, England), 2022

Guideline

Tratamento da Insônia com Zolpidem

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insomnia Management in Patients with PEG Tubes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment options for insomnia.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.